Pharmaceuticals

Pharma Grade Cellulose Powder Market 2025–2029: Tracking 6.1% CAGR Toward $1.97 Billion in Revenue

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pharma grade cellulose powder market from 2025–2034 with trusted insights from The Business Research Company

How Will The Pharma Grade Cellulose Powder Market Size Evolve Between Now And 2029?

The pharma grade cellulose powder market has experienced substantial growth in recent years. Its valuation is set to rise from $1.47 billion in 2024 to $1.55 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.8%. The historic expansion of this market can be ascribed to an escalating demand for tablet binders, the proliferation of generic drug manufacturing, increased pharmaceutical research and development initiatives, the broadening of excipient manufacturing capabilities, and successful regulatory approvals for cellulose-based excipients.

The pharma grade cellulose powder market size is projected to experience robust expansion in the coming years, with its value expected to reach $1.97 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period can be attributed to a surge in personalized medicine, the increasing adoption of sustainable excipients, the expansion of biologics and biosimilars, a growing focus on innovations in oral drug delivery, and rising investments in pharmaceutical infrastructure within emerging markets. Major trends anticipated during this period include a heightened demand for excipient-grade materials in drug formulation, increasing utilization in controlled-release drug delivery systems, a shift towards plant-based and renewable excipients, a rising adoption in controlled drug delivery systems, and advancements in cellulose processing technologies aimed at achieving higher purity and performance.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp

Which Key Drivers Are Powering Growth In The Pharma Grade Cellulose Powder Market?

The expansion of pharmaceutical manufacturing is anticipated to drive the demand for the pharma-grade cellulose powder market in the future. Pharmaceutical production encompasses the creation of medicines through the formulation, synthesis, and quality control of active ingredients and excipients, ensuring safety, efficacy, and adherence to regulations. This manufacturing is experiencing an upturn, primarily attributed to the increasing prevalence of chronic diseases that necessitate ongoing, long-term medication for proper management. Pharma-grade cellulose powder plays a crucial role in this process, serving as a reliable binder, filler, and stabilizer, which is vital for maintaining tablet integrity and ensuring even distribution of drugs. Illustratively, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association for the European pharmaceutical industry, indicated in June 2023 that Europe’s total pharmaceutical production reached $422,803 million ( €390,000 million) in 2023, representing an increase from $393,857 million (€363,300 million) in 2022. Consequently, the increasing volume of pharmaceutical production is a key driver for the growth of the pharma-grade cellulose powder market.

How Is The Global Pharma Grade Cellulose Powder Market Structured By Key Segments?

The pharma grade cellulose powder market covered in this report is segmented –

1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)

2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent

3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications

4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries

Subsegments:

1) By Microcrystalline Cellulose: Powder, Granules

2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants

3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)

4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)

What Future-Focused Trends Are Anticipated In The Pharma Grade Cellulose Powder Market?

Leading companies in the pharma-grade cellulose powder market are prioritizing the establishment of new microcrystalline cellulose facilities to enhance production capabilities and bolster their supply chain for pharmaceutical excipients. A microcrystalline cellulose facility is a specialized plant where refined cellulose undergoes precise chemical and mechanical treatments to yield uniform, fine-grade particles suitable for pharmaceutical applications. For example, in September 2023, Nitika Pharmaceuticals Specialties, an excipient manufacturing firm based in India, inaugurated Tabcell, India’s largest microcrystalline cellulose (MCC) manufacturing plant, located in Nagpur. This plant, which incorporates state-of-the-art technology and possesses an installed capacity of 1200 metric tons, was inaugurated by Union Minister Nitin Gadkari and marks a significant achievement under the Government of India’s Production Linked Incentive (PLI) scheme for excipients. The addition of this new facility strengthens Nitika Pharma’s status as a global leader in pharmaceutical excipients, meeting domestic requirements and supporting exports to over 92 countries, while also contributing to the “Make in India” initiative and fostering considerable local job creation.

Which Companies Hold A Competitive Edge In The Pharma Grade Cellulose Powder Market?

Major companies operating in the pharma grade cellulose powder market are Roquette Frères, Ashland Global, JRS Pharma, Ankit Pulps & Boards Pvt. Ltd., DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., Maple Biotech Pvt. Ltd., Mingtai Chemical Co. Ltd., Patel Chem Specialties Limited, CelluTech, RanQ, Aromatic Cellulose Pvt. Ltd., Maruti Chemicals, Weifang Lude Chemical Co., Ltd., Patco Pharmaceuticals Pvt. Ltd., RK Dyechem Private Limited, Chemfield Cellulose, Vizag chemical, Tirumala inorganics

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharma-grade-cellulose-powder-global-market-report

Which Region Is Expected To Lead The Pharma Grade Cellulose Powder Market In The Next Few Years?

North America was the largest region in the pharma-grade cellulose powder market in 2024. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24373&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Cellulose Powder Market 2025, By The Business Research Company

Pharma Microbiology Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

Ai In Pharma Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

Ai In Pharma Market 2025

https://www.thebusinessresearchcompany.com/report/ai-in-pharma-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795